RANDAL J KIRK Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is a Director in CLINICAL DATA INC ($NOVI) and a 10% Owner in AmpliPhi Biosciences Corp ($APHB) and a 10% Owner in Fibrocell Science, Inc. ($FCSC) and a 10% Owner in SOLIGENIX, INC. ($DOR) and a 10% Owner in Synthetic Biologics, Inc. ($SYN) and a 10% Owner in TRANSGENOMIC INC ($TBIO) and a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a 10% Owner in ORAGENICS INC ($OGEN) and a 10% Owner in INTREXON CORP ($XON) and an Chief Executive Officer in INTREXON CORP ($XON) and a Director in INTREXON CORP ($XON) and an Executive Chairman in INTREXON CORP ($XON) and a 10% Owner in HISTOGENICS CORP ($HSGX) and a 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Over the past year RANDAL J KIRK has been an insider in 2 companies. The total value of shares held by RANDAL J KIRK in these companies amounts to $392,445,214.

RANDAL J KIRK 10% Owner
AquaBounty Technologies, Inc.
10% Owner
Armata Pharmaceuticals, Inc.
Director
CLINICAL DATA INC
10% Owner
Fibrocell Science, Inc.
10% Owner, Director
HALOZYME THERAPEUTICS, INC.
10% Owner
Ocugen, Inc.
10% Owner
ORAGENICS INC
Executive Chairman, Chief Executive Officer, Director, 10% Owner
PRECIGEN, INC.
10% Owner
Precipio, Inc.
10% Owner
SOLIGENIX, INC.
10% Owner
Synthetic Biologics, Inc.
Director
ZIOPHARM ONCOLOGY INC
$ 392445214 The total value of shares held by RANDAL J KIRK
Insider Rank

RANDAL J KIRK ranks 186 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: THIRD SECURITY LLC THE GOVERNOR TYLER RADFORD 24141 VA

Companies in which RANDAL J KIRK is an Insider

AquaBounty Technologies, Inc.

Trading Symbol: AQB
Industry: FISHING, HUNTING & TRAPPING [0900]
Position of RANDAL J KIRK: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 12 2021
$AQB Market Capitalization: $88.78M
$AQB Previous Close: $15.76

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 54x
Sell: 4x
Shares Bought: 10,843,596
Shares Sold: 2,318,692
Share Difference: +8,524,904
Value Difference: -$43,086,604

Armata Pharmaceuticals, Inc.

Trading Symbol: APHB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 802,263 shares
Current Value: $433,222
Latest Transaction: Dec 29 2016
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 6x
Shares Bought: 428,571
Shares Sold: 177,020
Share Difference: +251,551
Value Difference: +$84,375

CLINICAL DATA INC

Trading Symbol: NOVI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 112,890 shares
Latest Transaction: Nov 13 2003

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Fibrocell Science, Inc.

Trading Symbol: FCSC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 80,160 shares
Current Value: $56,112
Latest Transaction: Dec 17 2019
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 4x
Shares Bought: 3,020,065
Shares Sold: 1,946,278
Share Difference: +1,073,787
Value Difference: +$3,738,834

HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner, Director
Holdings: 4,120,689 shares
Latest Transaction: Aug 28 2018

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 19x
Sell: 44x
Shares Bought: 5,418,607
Shares Sold: 11,468,978
Share Difference: -6,050,371
Value Difference: +$66,653,865

Ocugen, Inc.

Trading Symbol: HSGX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 2,438,770 shares
Current Value: $4,048,358
Latest Transaction: Jan 15 2019
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 3x
Shares Bought: 0
Shares Sold: 998,204
Share Difference: -998,204
Value Difference: +$158,772

ORAGENICS INC

Trading Symbol: OGEN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 14,481,089 shares
Current Value: $11,005,628
Latest Transaction: Jul 05 2016
$OGEN Market Capitalization: $38.33M
$OGEN Previous Close: $0.76

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 2,261,419
Shares Sold: 0
Share Difference: +2,261,419
Value Difference: -$1,166,666

PRECIGEN, INC.

Trading Symbol: XON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Executive Chairman, Chief Executive Officer, Director, 10% Owner
Holdings: 18,329,996 shares
Current Value: $392,445,214
Latest Transaction: Mar 29 2021
$XON Market Capitalization: $2.53B
$XON Previous Close: $21.41

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 423x
Sell: 33x
Shares Bought: 69,119,128
Shares Sold: 42,964,383
Share Difference: +26,154,745
Value Difference: -$259,853,035

Precipio, Inc.

Trading Symbol: PRPO
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of RANDAL J KIRK: 10% Owner
Holdings: 533,809 shares
Current Value: $373,666
Latest Transaction: Aug 30 2018
$PRPO Market Capitalization: $16.73M
$PRPO Previous Close: $0.70

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 10x
Sell: 12x
Shares Bought: 1,173,267
Shares Sold: 2,024,200
Share Difference: -850,933
Value Difference: -$3,294,278

SOLIGENIX, INC.

Trading Symbol: SNGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 583,334 shares
Latest Transaction: May 08 2017

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 7x
Shares Bought: 250,000
Shares Sold: 160,968
Share Difference: +89,032
Value Difference: +$301,882

Synthetic Biologics, Inc.

Trading Symbol: SYN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: 10% Owner
Holdings: 92,159 shares
Current Value: $78,335
Latest Transaction: Apr 03 2019
$SYN Market Capitalization: $76.50M
$SYN Previous Close: $0.85

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 6x
Shares Bought: 0
Shares Sold: 150,565
Share Difference: -150,565
Value Difference: +$98,837

ZIOPHARM ONCOLOGY INC

Trading Symbol: ZIOP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 139,513 shares
Current Value: $934,737
Latest Transaction: Oct 09 2018
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 17,204
Shares Sold: 0
Share Difference: +17,204
Value Difference: $0

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 29 2021XONPRECIGEN, INC.KIRK RANDAL JDirectorOption ExerciseA0.0032,425032,425
Mar 29 2021XONPRECIGEN, INC.KIRK RANDAL JDirectorOption ExerciseA5.6544,214249,80944,214
Mar 29 2021XONPRECIGEN, INC.KIRK RANDAL JDirectorGrantA7.7112,97099,99918,329,99618.3 M to 18.3 M (+0.07 %)
Mar 12 2021AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerOption ExerciseA6.722,50016,8002,500
Jan 05 2021XONPRECIGEN, INC.KIRK RANDAL JDirectorOption ExerciseM0.003,44406,887
Jan 05 2021XONPRECIGEN, INC.KIRK RANDAL JDirectorBuyM0.003,444018,317,02618.3 M to 18.3 M (+0.02 %)
Dec 21 2020XONPRECIGEN, INC.KIRK RANDAL JDirectorBuyJ0.008,10001,260,5381.3 M to 1.3 M (+0.65 %)

View all RANDAL J KIRK insider transactions.